Clinical Trial Update: A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a randomized Phase 1/2 study comparing ICE (irinotecan, cetuximab, everolimus) with CapOx (capecitabine, oxaliplatin) in gemci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• Everolimus (everolimus)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Per Pfeiffer | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED